|
1
|
Shu B, Feng Y, Gui Y, Lu Q, Wei W, Xue X,
Sun X, He W, Yang J and Dai C: Blockade of CD38 diminishes
lipopolysaccharide-induced macrophage classical activation and
acute kidney injury involving NF-κB signaling suppression. Cell
Signal. 42:249–258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poston JT and Koyner JL: Sepsis associated
acute kidney injury. BMJ. 364:k48912019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuzmich NN, Sivak KV, Chubarev VN, Porozov
YB, Savateeva-Lyubimova TN and Peri F: TLR4 signaling pathway
modulators as potential therapeutics in inflammation and sepsis.
Vaccines (Basel). 5:342017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song J, Fan HJ, Li H, Ding H, Lv Q and Hou
SK: Zingerone ameliorates lipopolysaccharide-induced acute kidney
injury by inhibiting Toll-like receptor 4 signaling pathway. Eur J
Pharmacol. 772:108–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anderberg SB, Luther T and Frithiof R:
Physiological aspects of Toll-like receptor 4 activation in
sepsis-induced acute kidney injury. Acta Physiol (Oxf).
219:573–588. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tran M, Tam D, Bardia A, Bhasin M, Rowe
GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV,
Saintgeniez M, et al: PGC-1α promotes recovery after acute kidney
injury during systemic inflammation in mice. J Clin Invest.
121:4003–4014. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takasu O, Gaut JP, Watanabe E, To K,
Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, et
al: Mechanisms of cardiac and renal dysfunction in patients dying
of sepsis. Am J Respir Crit Care Med. 187:509–517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jung YJ, Lee AS, Nguyen-Thanh T, Kim D,
Kang KP, Lee S, Park SK and Kim W: SIRT2 regulates LPS-induced
renal tubular CXCL2 and CCL2 expression. J Am Soc Nephrol.
26:1549–1560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HM, Park BS, Kim J-I, Kim SE, Lee J,
Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, et al: Crystal
structure of the TLR4-MD-2 complex with bound endotoxin antagonist
Eritoran. Cell. 130:906–917. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai B, Wang M, Zhu X, Xu J, Zheng W, Zhang
Y, Zheng F, Feng Z and Zhu J: The fab fragment of a humanized
anti-toll like receptor 4 (TLR4) monoclonal antibody reduces the
lipopolysaccharide response via TLR4 in mouse macrophage. Int J Mol
Sci. 16:25502–25515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang M, Zheng W, Zhu X, Xu J, Cai B, Zhang
Y, Zheng F, Zhou L, Yang Z, Zhang X, et al: A human anti-toll like
receptor 4 Fab fragment inhibits lipopolysaccharide-induced
pro-inflammatory cytokines production in macrophages. PLoS One.
11:e01468562016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Care NRCU and Animals AUOL; Guide for the
Care and Use of Laboratory Animals, : The National Academies
Collection: Reports funded by National Institutes of Health.
National Academies Press; Washington, DC: 2011
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye H-Y, Jin J, Jin L-W, Chen Y, Zhou Z-H
and Li Z-Y: Chlorogenic acid attenuates lipopolysaccharide-induced
acute kidney injury by inhibiting TLR4/NF-κB signal pathway.
Inflammation. 40:523–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wonnacott A, Meran S, Amphlett B, Talabani
B and Phillips A: Epidemiology and outcomes in community-acquired
versus hospital-acquired AKI. Clin J Am Soc Nephrol. 9:1007–1014.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoste EA, Bagshaw SM, Bellomo R, Cely CM,
Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, et
al: Epidemiology of acute kidney injury in critically ill patients:
The multinational AKI-EPI study. Intensive Care Med. 41:1411–1423.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song J, Yu J, Prayogo GW, Cao W, Wu Y, Jia
Z and Zhang A: Understanding kidney injury molecule 1: A novel
immune factor in kidney pathophysiology. Am J Transl Res.
11:1219–1229. 2019.PubMed/NCBI
|
|
19
|
Qin C: Medical laboratory zoology.
People's Health Publishing House. 51–57. 2015.
|
|
20
|
Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri
ND and Silva FG: The aging kidney. Kidney Int. 74:710–720. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hackbarth H and Harrison DE: Changes with
age in renal function and morphology in C57BL/6, CBA/HT6, and
B6CBAF1 mice. J Gerontol. 37:540–547. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Yang S, Zumbrun EE, Guan H,
Nagarkatti PS and Nagarkatti M: Resveratrol attenuates
lipopolysaccharide-induced acute kidney injury by suppressing
inflammation driven by macrophages. Mol Nutr Food Res. 59:853–864.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mortensen J, Shames B, Johnson CP and
Nilakantan V: MnTMPyP, a superoxide dismutase/catalase mimetic,
decreases inflammatory indices in ischemic acute kidney injury.
Inflamm Res. 60:299–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu D, Chen M, Ren X, Ren X and Wu Y:
Leonurine ameliorates LPS-induced acute kidney injury via
suppressing ROS-mediated NF-κB signaling pathway. Fitoterapia.
97:148–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cunningham PN, Wang Y, Guo R, He G and
Quigg RJ: Role of Toll-like receptor 4 in endotoxin-induced acute
renal failure. J Immunol. 172:2629–2635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Castoldi A, Braga TT, Correa-Costa M,
Aguiar CF, Bassi EJ, Correa-Silva R, Elias RM, Salvador F,
Moraes-Vieira PM, Cenedeze MA, et al: TLR2, TLR4 and the MYD88
signaling pathway are crucial for neutrophil migration in acute
kidney injury induced by sepsis. PLoS One. 7:e375842012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blackwell TS and Christman JW: The role of
nuclear factor-κ B in cytokine gene regulation. Am J Respir Cell
Mol Biol. 17:3–9. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee S-Y, Lee Y-S, Choi H-M, Ko YS, Lee HY,
Jo SK, Cho WY and Kim HK: Distinct pathophysiologic mechanisms of
septic acute kidney injury: Role of immune suppression and renal
tubular cell apoptosis in murine model of septic acute kidney
injury. Crit Care Med. 40:2997–3006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peerapornratana S, Manrique-Caballero CL,
Gómez H and Kellum JA: Acute kidney injury from sepsis: Current
concepts, epidemiology, pathophysiology, prevention and treatment.
Kidney Int. 96:1083–1099. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao L, Wu W-F, Dong L, Ren G-L, Li H-D,
Yang Q, Li X-F, Xu T, Li Z, Wu B-M, et al: Protocatechuic aldehyde
attenuates cisplatin-induced acute kidney injury by suppressing
nox-mediated oxidative stress and renal inflammation. Front
Pharmacol. 7:4792016. View Article : Google Scholar : PubMed/NCBI
|
